Viramune

Active Ingredient(s): Nevirapine
FDA Approved: * June 21, 1996
Pharm Company: * BOEHRINGER INGELHEIM
Category: HIV / AIDS

Nevirapine (NVP), sold under the brand name Viramune among others, is a medication used to treat and prevent HIV/AIDS, specifically HIV-1.[3] It is generally recommended for use with other antiretroviral medications.[3] It may be used to prevent mother to child spread during birth but is not recommended following other exposures.[3] It is taken by mouth.[3] Common side effects include rash, headache, nausea, feeling tired, and li... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Viramune 54;193
Viramune 200 mg Oral Tablet
NDC: 0597-0046
Labeler:
Boehringer Ingelheim Pharmaceuticals Inc.
Viramune V04;
24 Hr Viramune 400 mg Extended Release Tablet
NDC: 0597-0123
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.
Viramune 54;193
Viramune 200 mg Oral Tablet
NDC: 53808-0808
Labeler:
State of Florida Doh Central Pharmacy
Viramune 54;193
Viramune 200 mg Oral Tablet
NDC: 54569-4561
Labeler:
A-s Medication Solutions
Viramune V04;
Viramune 400 mg Oral Tablet, Extended Release
NDC: 54569-6236
Labeler:
A-s Medication Solutions
Viramune V04;
24 Hr Viramune 400 mg Extended Release Tablet
NDC: 54868-6370
Labeler:
Physicians Total Care, Inc.
Viramune 50 mg/5ml Oral Suspension
NDC: 0597-0047
Labeler:
Boehringer Ingelheim Pharmaceuticals Inc.
24 Hr Viramune 100 mg Extended Release Tablet
NDC: 0597-0129
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.

Related Brands

Drugs with the same active ingredients